Cabalin Capsule 50 mg (Pregabalin)

Adult dose

This medication, pregabalin, is to be taken orally, divided into two doses per day regardless of food. 1. Neuropathic Pain - Peripheral Neuropathic Pain: Starting dose of 150 mg per day, may be increased up to 300 mg per day after 3 to 7 days, and can be further increased to a maximum of 600 mg. - Central Neuropathic Pain: Starting dose of 150 mg per day, may be increased to 300 mg per day after 1 week.

Child dose

Safety and efficacy data in children under 12 years of age and adolescents aged 12 to 17 years are insufficient, and administration is not recommended.

This medication may increase the risk of suicidal thoughts or behaviors, so if there are changes in mood or depressive symptoms while taking it, you should consult a healthcare professional immediately. Do not administer if allergic to any of the ingredients, and patients with certain genetic disorders such as lactose intolerance should not take it. Diabetes patients may need to adjust the dosage of blood sugar control medications due to weight gain, and if symptoms of angioedema occur, the medication should be discontinued immediately. Elderly patients may experience increased dizziness or drowsiness when taking this medication, raising the risk of falls or accidents, so caution is necessary. Blurred vision or changes in eyesight may occur, so inform a healthcare professional if these symptoms arise. Abrupt discontinuation of this medication may lead to withdrawal symptoms such as insomnia, headache, anxiety, so it is recommended to consult with a healthcare professional before stopping. Patients with a history of substance abuse are at higher risk of misusing this medication, so caution is needed during administration, and monitoring for signs of misuse or dependency is necessary. Patients with impaired kidney function may need dose adjustments, and caution must be taken for patients with severe heart disease. Caution is required when co-administering this medication with opiate analgesics due to the risk of central nervous system depression and the possibility of serious adverse reactions such as respiratory depression. Pregnant women are advised not to take this medication due to the risk of fetal malformations in early pregnancy, and fertile women should use effective contraception. Breastfeeding women should discuss with a healthcare professional the possibility of this medication being transmitted through breast milk, and may need to discontinue either breastfeeding or the medication. Caution is warranted when engaging in hazardous activities such as driving or operating machinery due to the potential for dizziness or drowsiness after taking the medication. In case of overdose, confusion, drowsiness, and depression may occur, and treatment such as hemodialysis may be required. Keep this medication out of reach of children and do not transfer it to another container for safety.

Serious side effects

Hives, severe swelling (angioedema), chest tightness, difficulty breathing, cold sweat, pallor, severe rash with fever, blisters, skin peeling, pain in oral/ocular mucosa, shortness of breath or difficulty breathing, asthma attacks, respiratory abnormalities accompanied by cough and fever, yellowing of skin or eyes (jaundice), severe lethargy, sudden and severe headache, thunderclap headache, seizures, consciousness confusion, visual disturbances, paralysis,

Mild side effects

• Dizziness
• drowsiness
• confusion
• spatial disorientation
• irritability
• depression
• euphoria
• decreased libido
• insomnia
• depersonalization

This medication should be stored in a tightly sealed container to prevent air or moisture from entering. Also, avoid storing it in places that are too hot or too cold, and it is recommended to keep it at room temperature between 15 and 30 degrees Celsius.

Appearance

Hard capsule with a blue upper part and a white lower part filled with white or grayish-white powder

Package unit

30 capsules/bottle, 100 capsules/bottle